GNRH1 and metastatic prostate carcinoma: The cancer medications reported for the other MRONJ cases were: abiraterone (n = 2), leuprorelin (n = 1), GnRH agonist (n = 1) and radium-223 for metastatic prostate cancer, fulvestrant (n = 1) and everolimus (1) for advanced-stage breast cancer and lenalidomide (n = 3) to treat multiple myeloma.